Digest: The Act tells the State Board of Pharmacy to classify xylazine as a Schedule IV controlled substance. (Flesch Readability Score: 60.1).
Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.

Statutes affected:
Introduced: 475.005